Advertisement
Screener

Satsuma Pharmaceuticals, Inc. Form D

Satsuma Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2018-02-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-12-16; Total offering amount $12,288,750.
  • 2016-12-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-12-16; Total offering amount $12,288,750.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2018-02-12
D/A
Rule 506(b)Equity2016-12-16$12,288,750$12,134,401$154,3494
2016-12-29Rule 506(b)Equity2016-12-16$12,288,750$6,000,000$6,288,7503